Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
19,200
+7,500
+64% +$706K 0.1% 88
2026
Q1
$1.38M Buy
11,700
+1,500
+15% +$185K 0.2% 91
2025
Q4
$1.28M Buy
10,200
+750
+8% +$97.8K 0.17% 87
2025
Q3
$1.38M Sell
9,450
-2,700
-22% -$408K 0.2% 82
2025
Q2
$1.89M Buy
12,150
+1,200
+11% +$190K 0.3% 67
2025
Q1
$1.8M Sell
10,950
-1,200
-10% -$200K 0.34% 61
2024
Q4
$1.98M Buy
+12,150
New +$2.17M 0.35% 59

Other funds holding ZTS

Sava Infond's ZTS Position: Q2 2026 in Review

Sava Infond increased its Zoetis (ZTS) stake by 64% in Q2 2026, buying an estimated $706K and bringing the position to 19,200 shares worth $1.38M. The position accounts for 0.1% of the portfolio, ranked #88.

Sava Infond first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.98M in Q4 2024. 249 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Sava Infond held 19,200 shares of Zoetis worth $1.38M as of Q2 2026.
  • Sava Infond bought 7,500 Zoetis shares in Q2 2026, an estimated $706K.
  • Zoetis made up 0.1% of Sava Infond's portfolio in Q2 2026, its #88 holding.
  • Sava Infond first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Zoetis position peaked at $1.98M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.